...
首页> 外文期刊>European Journal of Medicinal Chemistry: Chimie Therapeutique >A comprehensive review of salinomycin derivatives as potent anticancer and anti-CSCs agents
【24h】

A comprehensive review of salinomycin derivatives as potent anticancer and anti-CSCs agents

机译:盐霉素衍生物的综合综述作为强化抗癌和抗CSCS代理人

获取原文
获取原文并翻译 | 示例

摘要

Polyether ionophore antibiotics (ionophores) represent a large group of more than 120 lipid-soluble compounds that are widely used in veterinary medicine because of their significant antimicrobial activity. In addition to the industrial use of ionophores, some of them effectively and selectively inhibit properties of different cancer cells and enhance the antitumor effects of chemo- and/or radiotherapy. Salinomycin (SAL) is particularly interesting in this regard as it shows potent activity against various types of cancer cells, including those that display multi-drug resistance, and cancer stem cells. Therefore, a very interesting direction of research is chemical modification of SAL which may lead to obtaining analogs that are characterized by better biological activity and lower toxicity than those of the starting compound. This review article is focused on the possible role of both SAL-based drug delivery systems and SAL derivatives in future cancer therapy. (C) 2019 Elsevier Masson SAS. All rights reserved.
机译:聚醚离子载体抗生素(离子团)代表大群超过120种脂质可溶性化合物,其由于其显着的抗微生物活性而广泛用于兽医。除了工业用途的离子群外,其中一些有效且选择性地抑制不同癌细胞的特性,并增强化学和/或放射疗法的抗肿瘤作用。在这方面,SALINOMYCIN(SAL)特别有趣,因为它显示出对各种类型的癌细胞的有效活性,包括显示多种耐药性和癌症干细胞的活性。因此,非常有趣的研究方向是SAL的化学改性,其可能导致获得表征的类似物,其特征在于比起始化合物的生物活性更好和较低的毒性。该审查文章专注于Sal基药物递送系统和SAL衍生物在未来癌症治疗中的可能作用。 (c)2019年Elsevier Masson SAS。版权所有。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号